These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15380859

  • 1. Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
    Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V, Liu-Seifert H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):985-96. PubMed ID: 15380859
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, de Oliveira IR, Tollefson GD.
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia.
    Dossenbach MR, Folnegovic-Smalc V, Hotujac L, Uglesic B, Tollefson GD, Grundy SL, Friedel P, Jakovljevic MM, Olanzapine HGCH Study Group.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):311-8. PubMed ID: 14751428
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
    Chan HY, Chiang SC, Chang CJ, Gau SS, Chen JJ, Chen CH, Hwu HG, Lai MS.
    J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726
    [Abstract] [Full Text] [Related]

  • 5. Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics.
    Kinon BJ, Kollack-Walker S, Jeste D, Gupta S, Chen L, Case M, Chen J, Stauffer V.
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):67-79. PubMed ID: 25009161
    [Abstract] [Full Text] [Related]

  • 6. Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
    Caroff SN, Davis VG, Miller DD, Davis SM, Rosenheck RA, McEvoy JP, Campbell EC, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA, CATIE Investigators.
    J Clin Psychiatry; 2011 Mar; 72(3):295-303. PubMed ID: 20816031
    [Abstract] [Full Text] [Related]

  • 7. Treatment of tardive dyskinesia with donepezil: a pilot study.
    Caroff SN, Campbell EC, Havey J, Sullivan KA, Mann SC, Gallop R.
    J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.
    Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A.
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1013-20. PubMed ID: 14618553
    [Abstract] [Full Text] [Related]

  • 9. Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics.
    Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Pondé de Sena E, Hotopf M.
    J Clin Psychiatry; 2005 Jul; 66(7):831-8. PubMed ID: 16013897
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine therapy in elderly patients with schizophrenia.
    Sajatovic M, Perez D, Brescan D, Ramirez LF.
    Psychopharmacol Bull; 1998 Jul; 34(4):819-23. PubMed ID: 10513458
    [Abstract] [Full Text] [Related]

  • 11. An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia.
    Mozes T, Ebert T, Michal SE, Spivak B, Weizman A.
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):393-403. PubMed ID: 16958565
    [Abstract] [Full Text] [Related]

  • 12. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T.
    Psychiatr Pol; 2014 Aug; 48(6):1155-65. PubMed ID: 25717485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I, Oumaya A, Bouguerra C, Mehdi F, Bellaaj R, Gallali S.
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM, Glick ID, Weiden PJ, Romano SJ, Siu CO.
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
    Kane JM, Correll CU, Liang GS, Burke J, O'Brien CF.
    Psychopharmacol Bull; 2017 Aug 01; 47(3):69-76. PubMed ID: 28839342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.